---
title: "seroprevalence_data_README"
output: html_document
date: "2024-02-20"
---

The nationwide blood donor seroprevalence survey estimates the
percentage of the U.S. population ages 16 and older that have
developed antibodies against SARS-CoV-2. The dataset includes 
seroprevalence from both infection and both vaccination (combined) 
and infection for three regions in California and one region in
North Carolina by major racial/ethnic groups. 

Source: https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence 

For any questions or issues please reach out to
sbents@alumni.princeton.edu.
